Varian Medical Systems, Inc.  

(Public, NYSE:VAR)   Watch this stock  
Find more results for VAR
84.72
+0.69 (0.82%)
Feb 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 83.56 - 84.79
52 week 66.86 - 93.97
Open 83.56
Vol / Avg. 748,990.00/1.10M
Mkt cap 7.98B
P/E 24.18
Div/yield     -
EPS 3.50
Shares 93.50M
Beta 0.69
Inst. own 101%
Mar 2, 2017
Varian Medical Systems Inc at BTIG Healthcare Conference Add to calendar
Feb 22, 2017
Varian Medical Systems Inc at RBC Capital Markets Healthcare Conference
Feb 10, 2017
Varian Medical Systems Inc Annual Shareholders Meeting (Estimated)
Feb 9, 2017
Varian Medical Systems Inc Annual Shareholders Meeting
Jan 25, 2017
Q1 2017 Varian Medical Systems Inc Earnings Call
Jan 25, 2017
Q1 2017 Varian Medical Systems Inc Earnings Release
Jan 10, 2017
Varian Medical Systems Inc at JPMorgan Healthcare Conference
Dec 7, 2016
Varian Medical Systems Inc at Citi Global Healthcare Conference
Nov 30, 2016
Varian Medical Systems Inc at Evercore ISI MedTools Conference
Nov 29, 2016
Varian Medical Systems Inc Investor Meeting at Radiological Society of North America (RSNA)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 2.75% 12.51%
Operating margin 5.03% 17.12%
EBITD margin - 20.29%
Return on average assets - -
Return on average equity - -
Employees 7,800 -
CDP Score - 93 B

Address

3100 Hansen Way
PALO ALTO, CA 94304-1030
United States - Map
+1-650-4245834 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.

Officers and directors

R. Andrew Eckert Independent Chairman of the Board
Age: 55
Bio & Compensation  - Reuters
Dow R. Wilson President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy E. Guertin Vice Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Elisha W. Finney Chief Financial Officer, Executive Vice President - Finance
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kolleen T. Kennedy Executive Vice President and President - Oncology Systems
Age: 57
Bio & Compensation  - Reuters
John W. Kuo Senior Vice President, General Counsel, Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Rafael Torres Senior Vice President - Business Development and Strategy
Bio & Compensation  - Reuters
Susan L. Bostrom Independent Director
Age: 56
Bio & Compensation  - Reuters
Judy Bruner Independent Director
Age: 58
Bio & Compensation  - Reuters
Regina E. Dugan Ph.D. Independent Director
Age: 53
Bio & Compensation  - Reuters